HRT Financial’s Marvell Technology MRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.1M Buy
213,000
+102,300
+92% +$8.59M 0.05% 327
2025
Q4
$9.41M Sell
110,700
-29,800
-21% -$2.61M 0.03% 484
2025
Q3
$11.8M Buy
140,500
+88,300
+169% +$6.5M 0.04% 334
2025
Q2
$4.04M Buy
52,200
+28,700
+122% +$1.79M 0.02% 629
2025
Q1
$1.45M Sell
23,500
-1,100
-4% -$107K 0.01% 953
2024
Q4
$2.72M Buy
+24,600
New +$2.28M 0.01% 624
2021
Q4
Sell
-21,900
Closed -$1.32M 3741
2021
Q3
$1.32M Buy
+21,900
New +$1.31M 0.01% 1038

Other funds holding MRVL

HRT Financial's MRVL Position: Q1 2026 in Review

HRT Financial increased its Marvell Technology (MRVL) stake by 89% in Q1 2026, buying an estimated $107M and bringing the position to 2,710,741 shares worth $268M. The position accounts for 0.67% of the portfolio, ranked #15.

HRT Financial first reported a position in MRVL in Q3 2016 and has held it in 16 quarters since. 1,536 funds tracked by Wall St. Rank hold MRVL as of Q1 2026.

  • HRT Financial held 2,710,741 shares of Marvell Technology worth $268M as of Q1 2026.
  • HRT Financial bought 1,273,265 Marvell Technology shares in Q1 2026, an estimated $107M.
  • Marvell Technology made up 0.67% of HRT Financial's portfolio in Q1 2026, its #15 holding.
  • HRT Financial first reported a position in Marvell Technology in Q3 2016 and has held it in 16 quarters since.
  • 1,536 funds tracked by Wall St. Rank held Marvell Technology as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.